Response to Comments: Implantable Continuous Glucose Monitors (I-CGM)

This document (A59909) is a response-to-comments record for the Implantable Continuous Glucose Monitors (I-CGM) policy L38662 and does not itself define clinical coverage criteria. It documents that the public comment period ran from 10/12/2023 to 11/25/2023 and that submitted comments were reviewed and consolidated for response. For specific coverage, indications, limitations, and claim documentation requirements, refer to the underlying policy L38662.

"Public comment period for Implantable Continuous Glucose Monitors (I-CGM) L38662 opened 2023-10-12 and closed 2023-11-25; comments were received, reviewed, and similar topics were aggregated and re..."

Sign up to see full coverage criteria, indications, and limitations.